Fortive — Oct 29, 2025 release

Financial Highlights for Third Quarter 2025, Continuing Operations • Revenue of $1.03 billion, up 2.3% year-over-year; core revenue up 1.9% • GAAP net income of $117 million, 11.4% margin, up 4.9% year-over-year; adjusted EBITDA of $309 million, 30.1% margin, up 10.4% year-over-year • GAAP diluted net EPS of $0.35, up 9.4% year-over-year; adjusted diluted net EPS of $0.68, up 15.3% year-over-year • GAAP operating cash flow of $295 million, Trailing Twelve Months (TTM) GAAP operating cash flow of $1,019 million; Free Cash Flow of $266 million, TTM Free Cash Flow of $922 million • Deployed $1.0 billion towards share repurchases in the third quarter Raising Full Year 2025 Guidance, Continuing Operations For the full year 2025, Fortive now anticipates adjusted diluted net earnings per share of $2.63 to $2.67, as compared to our prior expectation of $2.50 to $2.60. 1 Summary Financial Results, Continuing Operations Fortive Continuing Operations Q3-25 Q3-24 Variance Revenue $1,027M $1,004M 2.3% / 1.9% (reported / core) GAAP Net Income $117M $111M 4.9% GAAP Net Income margin 11.4% 11.1% 30 bps Adj. EBITDA $309M $280M 10.4% Adj. EBITDA margin 30.1% 27.9% 220 bps GAAP diluted net earnings per share $0.35 $0.32 9.4% Adj. diluted net earnings per share $0.68 $0.59 15.3% GAAP Operating cash flow $295M $305M (3.3)% Free cash flow $266M $283M (6.0)% TTM GAAP Operating cash flow $1,019M $961M 6.1% TTM Free cash flow $922M $874M 5.5% Summary Segment Financial Results, Continuing Operations Intelligent Operating Solutions Q3-25 Q3-24 Variance Revenue $699M $681M 2.6% / 2.2% (reported / core) GAAP Operating profit $181M $169M 6.9% GAAP Operating margin 25.9% 24.8% 110 bps Adj. EBITDA $242M $227M 6.7% Adj. EBITDA margin 34.6% 33.3% 130 bps Advanced Healthcare Solutions Q3-25 Q3-24 Variance Revenue $328M $322M 1.9% / 1.1% (reported / core) GAAP Operating profit $43M $37M 15.8% GAAP Operating margin 12.9% 11.4% 150 bps Adj. EBITDA $92M $87M 6.6% Adj. EBITDA margin 28.1% 26.9% 120 bps 2 PRECISION TECHN